https://sputniknews.in/20240404/india-launches-first-indigenous-affordable-gene-therapy-for-cancer-7038790.html
India Launches First Indigenous Affordable Gene Therapy for Cancer
India Launches First Indigenous Affordable Gene Therapy for Cancer
Sputnik India
The scientists at IIT Bombay have developed an indigenous cancer treatment using 'CAR-T cell therapy', a form of immunotherapy that genetically modifies a patient's white blood cells to combat cancer cells.
2024-04-04T19:18+0530
2024-04-04T19:18+0530
2024-04-04T19:18+0530
political affairs
india
droupadi murmu
health
science & tech
cancer
lung cancer
breast cancer
science diplomacy
health crisis
https://cdn1.img.sputniknews.in/img/07e8/02/09/6502542_3:0:739:414_1920x0_80_0_0_d9ddcba8cbb702f1ac292648e340f248.jpg
India's President Droupadi Murmu formally inaugurated the nation's first indigenous gene therapy and the world's most cost-effective "CAR-T cell therapy" for cancer at the Indian Institute of Technology (IIT) Bombay on Thursday.CAR-T cell therapy has shown promising results in clinical trials and is expected to significantly lower the cost of cancer treatment for Indian patients.This breakthrough represents a significant milestone in India's efforts to make advanced medical treatments more accessible to its population.During the launch, the president praised the Indian Institute of Technology, Bombay, Tata Memorial Hospital, and industry partner ImmunoACT for their remarkable achievement in developing affordable gene therapy.She emphasized that CAR-T cell therapy is one of the most groundbreaking advancements in medical science. It has been available in developed nations for some time, but it is extremely costly, and beyond the reach of most cancer patients around the world. However, India's CAR-T cell therapy is the most cost-effective therapy available worldwide.She also emphasized that the launch exemplifies the "Make in India" initiative, serving as a brilliant showcase for "Atmanirbhar Bharat" ("Self-Reliant India").
https://sputniknews.in/20240209/indias-indigenous-cancer-treatment-car-t-cell-therapy-cures-its-first-patient-6501400.html
india
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2024
Sangeeta Yadav
https://cdn1.img.sputniknews.in/img/07e6/0c/0f/110602_0:0:641:640_100x100_80_0_0_c298016a79eb02ef8caa9d1f688c12a5.jpg
Sangeeta Yadav
https://cdn1.img.sputniknews.in/img/07e6/0c/0f/110602_0:0:641:640_100x100_80_0_0_c298016a79eb02ef8caa9d1f688c12a5.jpg
News
en_IN
Sputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
https://cdn1.img.sputniknews.in/img/07e8/02/09/6502542_95:0:647:414_1920x0_80_0_0_098cfebfe6e21835f629dc74e598acd7.jpgSputnik India
feedback.hindi@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sangeeta Yadav
https://cdn1.img.sputniknews.in/img/07e6/0c/0f/110602_0:0:641:640_100x100_80_0_0_c298016a79eb02ef8caa9d1f688c12a5.jpg
scientists, indian institute of technology (iit) bombay, indigenous cancer treatment, car-t cell therapy, immunotherapy, genetic modification, white blood cells, cancer cells, india's president, droupadi murmu, clinical trials, low cost of cancer treatment, medical treatment, population, tata memorial hospital, immunoact, affordable gene therapy, medical science, make in india initiative, atmanirbhar bharat, self-reliant india
scientists, indian institute of technology (iit) bombay, indigenous cancer treatment, car-t cell therapy, immunotherapy, genetic modification, white blood cells, cancer cells, india's president, droupadi murmu, clinical trials, low cost of cancer treatment, medical treatment, population, tata memorial hospital, immunoact, affordable gene therapy, medical science, make in india initiative, atmanirbhar bharat, self-reliant india
India Launches First Indigenous Affordable Gene Therapy for Cancer
Scientists at the Indian Institute of Technology (IIT) Bombay have developed an indigenous cancer treatment using “CAR-T cell therapy”, a form of immunotherapy that genetically modifies a patient's white blood cells to combat cancer cells.
India's President Droupadi Murmu formally inaugurated the nation's first indigenous gene therapy and the world's most cost-effective "CAR-T cell therapy" for cancer at the Indian Institute of Technology (IIT) Bombay on Thursday.
CAR-T cell therapy has shown promising results in clinical trials and is expected to significantly lower the cost of cancer treatment for Indian patients.
This breakthrough represents a significant milestone in India's efforts to make advanced medical treatments more accessible to its population.
During the launch, the president praised the Indian Institute of Technology, Bombay, Tata Memorial Hospital, and industry partner ImmunoACT for their remarkable achievement in developing affordable gene therapy.
She emphasized that CAR-T cell therapy is one of the most
groundbreaking advancements in medical science. It has been available in developed nations for some time, but it is extremely costly, and beyond the reach of most
cancer patients around the world. However, India's CAR-T cell therapy is the most cost-effective therapy available worldwide.
She also emphasized that the launch exemplifies the "Make in India" initiative, serving as a brilliant showcase for "Atmanirbhar Bharat" ("Self-Reliant India").